miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.
Lin Y, Cheng K, Wang T, Xie Q, Chen M, Chen Q, Wen Q.
Lin Y, et al.
Biomed Pharmacother. 2017 Nov;95:1718-1724. doi: 10.1016/j.biopha.2017.09.074. Epub 2017 Oct 6.
Biomed Pharmacother. 2017.
PMID: 28962076
Retracted.
Subsequently, AKT3 was identified as a target of miR-217 in thyroid cancer. AKT3 expression was upregulated in thyroid cancer tissues, was inversely correlated with miR-217expression. Besides, overexpression of AKT3 efficiently abrogates suppressive effect on prolif …
Subsequently, AKT3 was identified as a target of miR-217 in thyroid cancer. AKT3 expression was upregulated in thyroid cancer …